Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders
US9315568B2 · kind B2 · utility
0Cited by
16References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 1, 2013 |
| Grant date | Apr 19, 2016 |
| Priority date | — |
| Expiry date | Dec 26, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to Cadherin-11 antagonists and compositions comprising Cadherin-11 antagonists. The invention also relates to methods for treating inflammatory joint disorders, such as rheumaotid arthritis, in a mammalian subject by administering a therapeutically effective amount of a Cadherin-11 antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.